18 research outputs found

    Addition of Lidocaine Injection Immediately before Physiotherapy for Frozen Shoulder: A Randomized Controlled Trial

    No full text
    <div><p>The intraarticular injection of lidocaine immediately before a physiotherapy session may relieve pain during the stretching and mobilization of the affected joint in patients with a frozen shoulder, thus enhancing the treatment effect. To compare the effects of intraarticular injection of lidocaine plus physiotherapy to that of physiotherapy alone in the treatment of a frozen shoulder, a prospective randomized controlled trial was conducted in the rehabilitation department of a private teaching hospital. Patients with a frozen shoulder were randomized into the physiotherapy group or the lidocaine injection plus physiotherapy (INJPT) group. The subjects in the INJPT group underwent injection of 3 ml of 1% lidocaine into the affected shoulder 10 to 20 minutes before each physiotherapy session. In each group, the treatment lasted 3 months. The primary outcome measures were the active and passive range of motion of the affected shoulder. The secondary outcome measures were the results of the Shoulder Disability Questionnaire, the Shoulder Pain and Disability Index, and the 36-item Short-Form Health Survey (SF-36). The outcome measures were evaluated before treatment and 1, 2, 3, 4, and 6 months after the start of treatment. The group comparisons showed significantly greater improvement in the INJPT group, mainly in active and passive shoulder range of motion in flexion and external rotation and improvements in pain and disability (<i>P</i> < 0.05); however, no significant group difference was seen in the SF-36 results. The intraarticular injection of lidocaine immediately before a physiotherapy session might be superior to physiotherapy alone in the treatment of a frozen shoulder.</p><p>Trial Registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/results?term=LIN+FEN+HSIEH&Search=Search" target="_blank">NCT01817348</a></p></div

    Comparisons of the active and passive ROMs between the groups.

    No full text
    <p>Shown as bar charts for (a) flexion, (b) abduction, (c) external rotation, and (d) internal rotation for active ROM and for (e) flexion, (f) abduction, (g) external rotation, and (h) internal rotation for passive ROM with the corresponding standard deviations represented as error bars. An asterisk indicates significant differences between groups (<i>P</i><0.008). For the evaluation times (evaluation times: before and 1, 2, 3, 4, and 6 months after the start of treatment), a right arrow above the graph indicates a significant, linearly increasing trend, whereas a left arrow indicates a significant, linearly decreasing trend (<i>P</i><0.025). (Black bar: the PT group; gray bar: the INJPT group). Group differences were analyzed using Mann-Whitney <i>U</i> test. Treatment time effects were analyzed using Friedman's test for two groups respectively. Abbreviations: PT, physical therapy; INJPT, injection plus physical therapy.</p

    In planta detection of <i>Fusarium oxypsorum</i> f. sp. <i>cubense</i> race 4 in field-infected banana by insulated isothermal polymerase chain reaction (iiPCR) method.

    No full text
    <p>In planta detection of <i>Fusarium oxypsorum</i> f. sp. <i>cubense</i> race 4 in field-infected banana by insulated isothermal polymerase chain reaction (iiPCR) method.</p

    Diagrammatic representations of the insulated isothermal PCR (iiPCR) assay, the POCKIT<sup>â„¢</sup> Nucleic Acid Analyzer, and the R-tube<sup>â„¢</sup>.

    No full text
    <p>(A) The iiPCR, established on the basis of the Rayleigh-Bénard convective PCR method, is a rapid platform for nucleic acid amplification. (B) The iiPCR system is carried out in the R-tube<sup>™</sup> within the user-friendly POCKIT<sup>™</sup> Nucleic Acid Analyzer designed by GeneReach Biotechnology Corporation (Taichung City, Taiwan). The POCKIT<sup>™</sup> analyzer (28 × 25 × 8.5 cm, W × D × H) provides isothermal heating at the bottom of the R-tube<sup>™</sup> to generate a cycling thermal convection to drive the PCR reaction. DNA amplification and product detection can be completed automatically by the POCKIT<sup>™</sup> analyzer with a single default program.</p

    Development of a TaqMan Probe-Based Insulated Isothermal Polymerase Chain Reaction (iiPCR) Assay for Detection of <i>Fusarium oxysporum</i> f. sp. <i>cubense</i> Race 4

    No full text
    <div><p>This study developed a novel and inexpensive detection method based on a TaqMan probe-based insulated isothermal polymerase chain reaction (iiPCR) method for the rapid detection of Panama disease caused by <i>Fusarium oxysporum</i> f. sp. <i>cubense</i> (Foc) race 4, which is currently among the most serious fungal vascular diseases worldwide. By using the portable POCKIT<sup>â„¢</sup> device with the novel primer set iiFoc-1/iiFoc-2, the Foc race 4 iiPCR assay (including DNA amplification and signal monitoring) could be completed within one hour. The developed Foc race 4 iiPCR assay is thus a user-friendly and efficient platform designed specifically for the detection of Foc race 4. The detection limit of this optimized Foc iiPCR system was estimated to be 1 copy of the target standard DNA as well as 1 fg of the Foc genomic DNA. This approach can serve as a rapid detection method for in planta detection of Foc race 4 in field-infected banana. It was concluded that this molecular detection procedure based on iiPCR has good potential for use as an efficient detection method.</p></div
    corecore